comparemela.com

Latest Breaking News On - Exchange commission electronic document gathering - Page 5 : comparemela.com

Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune and Kidney-related Diseases

Assets expand immunology portfolio to include B-cell therapy and macrophage modulation - - IND-enabling studies are ongoing and will support the transition of these assets to clinical development in 20222023 - Aurinia Pharmaceuticals Inc. today announced the addition of two novel assets that will expand the Company’s rare autoimmune and kidney-related disease pipeline. “Over the past year, in anticipation of .

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.